Does Internal Mammary Node Irradiation Have Survival Benefit for Clinical Stage, II-III Breast Cancer Patients After Neoadjuvant Chemotherapy?

被引：0
|
作者：
Kim, K. [1 ]
Noh, J. [2 ]
Kim, Y. [1 ]
Chang, J. [1 ]
Keum, K. [1 ]
Huh, S. [2 ]
Choi, D. [2 ]
Park, W. [2 ]
Suh, C. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiat Oncol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.670
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1026
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Internal Mammary Node Irradiation Improves Survival for Patients with Clinical Stage II-III Breast Cancer and Treated with Neoadjuvant Chemotherapy
    Luo, J.
    Jin, K.
    Chen, X.
    Yang, Z.
    Zhang, L.
    Mei, X.
    Ma, J.
    Zhang, Z.
    Shao, Z.
    Yu, X.
    Guo, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S217 - S217
  • [2] Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy?
    Kim, Kyung Hwan
    Noh, Jae Myoung
    Kim, Yong Bae
    Chang, Jee Suk
    Keum, Ki Chang
    Huh, Seung Jae
    Choi, Doo Ho
    Park, Won
    Suh, Chang-Ok
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 589 - 599
  • [3] Internal Mammary Node Irradiation (IMNI) Improves Survival Outcome for Patients With Clinical Stage II-III Breast Cancer After Preoperative Systemic Therapy
    Luo, Jurui
    Jin, Kairui
    Chen, Xingxing
    Wang, Xuanyi
    Yang, Zhaozhi
    Zhang, Li
    Mei, Xin
    Ma, Jinli
    Zhang, Xiaomeng
    Zhou, Zhirui
    Wang, Xiaofang
    Jiang, Yizhou
    Shao, Zhimin
    Zhang, Zhen
    Guo, Xiaomao
    Yu, Xiaoli
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (04): : 895 - 904
  • [4] Does internal mammary node irradiation affect treatment outcome in clinical stage II–III breast cancer patients receiving neoadjuv ant chemotherapy?
    Kyung Hwan Kim
    Jae Myoung Noh
    Yong Bae Kim
    Jee Suk Chang
    Ki Chang Keum
    Seung Jae Huh
    Doo Ho Choi
    Won Park
    Chang-Ok Suh
    Breast Cancer Research and Treatment, 2015, 152 : 589 - 599
  • [5] Metformin with neoadjuvant chemotherapy in stage II-III breast cancer: A phase II clinical trial
    Azazy, H. A.
    Gado, N. M.
    Salem, D. A.
    El-Ghamry, W. R.
    ANNALS OF ONCOLOGY, 2020, 31 : S323 - S324
  • [6] Role of Postmastectomy Radiation After Neoadjuvant Chemotherapy in Stage II-III Breast Cancer
    Fowble, Barbara L.
    Einck, John P.
    Kim, Danny N.
    McCloskey, Susan
    Mayadev, Jyoti
    Yashar, Catheryn
    Chen, Steven L.
    Hwang, E. Shelley
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 494 - 503
  • [7] Postmastectomy Radiation Therapy Improved Locoregional Control in Patients With Clinical Stage II-III Breast Cancer After Neoadjuvant Chemotherapy
    Cao, L.
    Chen, J.
    Xu, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E40 - E41
  • [8] SURVIVAL AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR ELDER PATIENTS WITH STAGE II-III RECTAL CANCER
    Anido, U.
    Castro-Gomez, E.
    Gomez-Caamano, A.
    Areses Manrique, M. C.
    Varela-Pazos, A.
    Garcia, J.
    Fernandez-Fernandez, E.
    Peleteiro, P.
    Gallardo, E.
    Lopez, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 143 - 143
  • [9] IS REGIONAL LYMPH NODE IRRADIATION NECESSARY IN STAGE II TO III BREAST CANCER PATIENTS WITH NEGATIVE PATHOLOGIC NODE STATUS AFTER NEOADJUVANT CHEMOTHERAPY?
    Daveau, Caroline
    Stevens, Denise
    Brain, Etienne
    Berges, Oscar
    Villette, Sylviane
    Moisson, Patricia
    Gardner, Miriam
    De la Lande, Brigitte
    Lasry, Serge
    Labib, Alain
    Le Scodan, Romuald
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (02): : 337 - 342
  • [10] Neoadjuvant biweekly chemotherapy with liposomal doxorubicin and docetaxel in patients with stage II-III breast cancer
    Alvarez, I
    Modolell, A.
    Mayordomo, J., I
    Heras, L.
    Villadiego, K.
    Rolfo, C. D.
    Garcia-Bueno, J. M.
    Pica, P.
    Murillo, L.
    Morales, S.
    Valera, P.
    Florian, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
12345